Ali Salanti Selected Research

Glycosaminoglycans

12/2022	Noninvasive detection of any-stage cancer using free glycosaminoglycans.
1/2022	Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer.
12/2021	The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility.
1/2020	A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine.
1/2019	Fighting Cancer Using an Oncofetal Glycosaminoglycan-Binding Protein from Malaria Parasites.
1/2017	An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
12/2016	Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility.
10/2015	Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.
2/2014	Characterization of human placental glycosaminoglycans and regional binding to VAR2CSA in malaria infected erythrocytes.
7/2003	Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ali Salanti Research Topics

Disease

88	Malaria 12/2023 - 07/2003
22	Neoplasms (Cancer) 04/2023 - 10/2015
22	Infections 01/2022 - 01/2008
8	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021 - 01/2003
4	COVID-19 01/2023 - 10/2021
3	Circulating Neoplastic Cells 06/2022 - 01/2018
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2017
2	Human Influenza (Influenza) 07/2020 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2015
2	Noncommunicable Diseases 01/2018 - 04/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Breakthrough Infections 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Adenocarcinoma 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021
1	Type I Syndactyly 10/2019
1	Glioma (Gliomas) 01/2019
1	Papillomavirus Infections 01/2019
1	Anemia 01/2018
1	Parasitemia 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2016
1	Parasitic Diseases (Parasitic Disease) 11/2016
1	Hypersensitivity (Allergy) 04/2016
1	Choriocarcinoma 01/2016
1	Premature Birth (Birth, Premature) 05/2015
1	Birth Weight (Birth Weights) 05/2015

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 04/2023 - 02/2008
33	Chondroitin Sulfates (Chondroitin Sulfate)IBA 04/2023 - 07/2003
28	VaccinesIBA 01/2023 - 07/2006
26	AntibodiesIBA 11/2022 - 11/2004
21	AntigensIBA 01/2021 - 06/2008
11	Immunoglobulin G (IgG)IBA 01/2023 - 06/2007
10	GlycosaminoglycansIBA 12/2022 - 07/2003
10	Proteoglycans (Proteoglycan)IBA 09/2021 - 10/2008
8	EpitopesIBA 11/2022 - 11/2006
7	ChondroitinIBA 12/2021 - 07/2003
7	Surface Antigens (Surface Antigen)IBA 04/2012 - 07/2003
5	Plasmodium falciparum erythrocyte membrane protein 1IBA 10/2021 - 12/2006
4	LigandsIBA 01/2021 - 01/2016
3	Malaria VaccinesIBA 12/2023 - 11/2016
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 06/2007
3	Monoclonal AntibodiesIBA 11/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2023
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2023 - 07/2020
2	Immunoglobulin M (IgM)IBA 01/2023 - 05/2010
2	Epithelial Cell Adhesion MoleculeIBA 06/2022 - 01/2018
2	Chondroitin Sulfate ProteoglycansIBA 01/2022 - 12/2020
2	CarbohydratesIBA 01/2021 - 01/2020
2	Hemagglutinins (Hemagglutinin)IBA 07/2020 - 01/2017
2	Indicators and Reagents (Reagents)IBA 03/2020 - 01/2017
2	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2020 - 01/2013
2	Recombinant ProteinsIBA 01/2017 - 11/2016
2	CytokinesIBA 01/2017 - 09/2016
2	Immune Sera (Antisera)IBA 10/2011 - 04/2005
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	AndrogensIBA 01/2022
1	LectinsIBA 01/2022
1	AcetylgalactosamineIBA 12/2021
1	NanovaccinesIBA 10/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	Single-Chain AntibodiesIBA 01/2021
1	Collodion (Nitrocellulose)IBA 01/2020
1	EmulsionsIBA 10/2019
1	saponin QA-21V1 (QS21)IBA 10/2019
1	Aluminum Hydroxide (Algeldrate)FDA Link 10/2019
1	LipidsIBA 10/2019
1	Virulence Factors (Pathogenicity Factors)IBA 10/2019
1	Immunodominant EpitopesIBA 10/2019
1	Peptides (Polypeptides)IBA 10/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	chondroitin sulfate proteoglycan 4IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	SugarsIBA 01/2017
1	IntegrinsIBA 12/2016
1	chondroitin sulfate glycosaminoglycanIBA 12/2016
1	src-Family KinasesIBA 12/2016
1	Interleukin-10 (Interleukin 10)IBA 09/2016
1	ParaffinIBA 07/2016
1	Formaldehyde (Formol)FDA Link 07/2016
1	AutoantigensIBA 04/2016
1	Syndecan-1 (Syndecan 1)IBA 01/2016
1	hemiasterlinIBA 10/2015
1	Diphtheria ToxinIBA 10/2015
1	Immunoglobulin FragmentsIBA 01/2014

Therapy/Procedure

10	Therapeutics 04/2023 - 09/2010
1	Castration 01/2022
1	Immunotherapy 11/2021
1	Intramuscular Injections 10/2019
1	Drug Therapy (Chemotherapy) 01/2017
1	Neoadjuvant Therapy 01/2017
1	Insecticide-Treated Bednets 03/2016